Thank you for reading the news about Saudi education witnesses rapid transformation in last five years and now with the details
Jeddah - Yasmine El Tohamy - FRANKFURT: Belen Garijo will take over as CEO at German pharmaceuticals giant Merck from May — the first woman to single-handedly run a DAX 30-listed company — as Europe’s top economy debates quotas for greater boardroom equality.
Spanish-born Garijo, 60, currently serves as the group’s deputy chief executive officer and head of its healthcare unit and says she is not content to be a one-off.
“It’s more important to me not to be the last woman at the top of a company than to be the only one,” the trained doctor recently told the daily Frankfurter Allgemeine Zeitung.
She is replacing Stefan Oschmann, 63, whose term ended after five years at the helm of the Darmstadt-based, family-owned group, which had never had a female chief executive in its 350-year history. Garijo, a mother of two and a passionate Real Madrid supporter, is making history as the first solo female leader of a firm listed on Frankfurt’s blue-chip DAX 30 index.
German software group SAP made the first cracks in the glass ceiling in 2019 when it appointed Jennifer Morgan as co-CEO alongside a male executive.
However she bowed out last year after just six months, as SAP decided to switch back to a sole chief executive — Christian Klein — to steer it through the pandemic upheaval.
Although Germany has been run by a woman chancellor for nearly 16 years and Christine Lagarde heads the Frankfurt-based European Central Bank, female top executives remain a rare sight in Europe’s leading economy.
Germany’s gender pay gap is also one of the largest in Europe, with women earning about 21 percent less than men on average. But things are changing.
The German government introduced legislation in 2015 requiring women to make up 30 percent of supervisory board seats in large companies, and Chancellor Angela Merkel’s Cabinet approved plans in January to introduce similar rules for executive boards.
Garijo, who previously ran Sanofi’s European operations, joined Merck’s healthcare unit in 2011. She has been credited with overhauling the department’s research and development and refocusing attention on fewer drugs with better prospects, boosting sales and profits, according to the Handelsblatt financial daily.
The group has been among those at the forefront of the fight against COVID-19 by delivering lipids used in the production of the Pfizer-BioNTech vaccine.
Garijo for her part puts her success down to “hard work” and to having seized her chances “when they arose.”
She is not, however, a fan of legal quotas to promote women, even in the face of middling results from voluntary measures by industry.
“I am against all forms of discrimination, including positive discrimination,” she said.
These were the details of the news Saudi education witnesses rapid transformation in last five years for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Arab News and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.